Showing posts with label pandemic influenza. Show all posts
Showing posts with label pandemic influenza. Show all posts

Saturday, November 21, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Nov. 21 '26)

 


    Ann Intern Med

  1. REIS G, Dos Santos Moreira Silva EA, Medeiros Silva DC, Thabane L, et al
    Effect of Fluvoxamine and Metformin for Fatigue in Patients With Long COVID : An Adaptive Randomized Trial.
    Ann Intern Med. 2026 Oct 6. doi: 10.7326/ANNALS-26-02144.
    PubMed         Abstract available


    Epidemiol Infect

  2. CHEN Y, Li J, Luo F, Ling F, et al
    Epidemiology of influenza before, during, and after the COVID-19 pandemic in China: An observational study from Zhejiang, China (2010-2023).
    Epidemiol Infect. 2026 Nov 20:1-14. doi: 10.1017/S0950268826102465.
    PubMed        


    J Infect Dis

  3. YANG Y, Smith M, Ho F, Truscon R, et al
    A prospective, comparative cohort analysis of influenza antibody waning in Michigan and Hong Kong during periods of low influenza circulation.
    J Infect Dis. 2026 Nov 17:jiag559. doi: 10.1093.
    PubMed         Abstract available

  4. HOSSAIN MP, Chen D, Yeung A, Adam DC, et al
    Inferring Diagnostic Serial Intervals to Understand COVID-19 Transmission Dynamics in Hong Kong and Mainland China.
    J Infect Dis. 2026;234:e1236-e1246.
    PubMed         Abstract available

  5. RATU A, Rabukawaqa I, McGregor R, Sassen J, et al
    Neutralisation capacity against SARS-CoV-2 ancestral, Delta and Omicron variants before and after heterologous booster vaccination in Fijian health system workers.
    J Infect Dis. 2026 Jul 17:jiag363. doi: 10.1093.
    PubMed         Abstract available

  6. BORRIELLO F, Koh GCKW, Troconiz IF, Nassirpour R, et al
    Randomized, Double-Blind, Placebo-Controlled First-in-Human Trial of a First-in-Class AI-Designed Monoclonal Antibody (GB-0669) Against the Conserved SARS-CoV-2 Spike S2 Stem Helix.
    J Infect Dis. 2026;234:747-757.
    PubMed         Abstract available


    J Virol

  7. WANG M, Zhao C, Peng R, Bai S, et al
    Structural basis of avian-to-human receptor-binding adaptation in H9Ny influenza A virus hemagglutinin.
    J Virol. 2026 Nov 18:e0151126. doi: 10.1128/jvi.01511.
    PubMed         Abstract available

  8. BARKHYMER AJ, Becker JT, Shepherd FK, Mickelson CK, et al
    A chicken interferon-stimulated gene screen reveals limited genes restricting influenza virus replication.
    J Virol. 2026 Nov 17:e0124326. doi: 10.1128/jvi.01243.
    PubMed         Abstract available

  9. COLARUSSO A, Stephenson KE, Collier A-RY, Wegmann F, et al
    Early innate immune signatures correlate with Ad26.COV2.S vaccine immunogenicity and protective efficacy.
    J Virol. 2026 Oct 26:e0149426. doi: 10.1128/jvi.01494.
    PubMed         Abstract available

  10. ULUSAN S, Markmann AJ, Vanna UP, Castillo I, et al
    Pooled intravenous immunoglobulins exhibit broad binding and Fc-mediated activity against diverse SARS-CoV-2 variants.
    J Virol. 2026 Oct 22:e0147126. doi: 10.1128/jvi.01471.
    PubMed         Abstract available

  11. KEITH AD, Keen MM, Frank F, Lam WA, et al
    Variant escape site mapping and characterization of SARS-CoV-2 nucleocapsid rapid antigen test antibodies.
    J Virol. 2026 Oct 14:e0100126. doi: 10.1128/jvi.01001.
    PubMed         Abstract available

  12. DIONNE K, Belanger E, Benlarbi M, Beaudoin-Bussieres G, et al
    Pre-existing cross-subtype serological responses against H5Nx in health care workers.
    J Virol. 2026;100:e0131026.
    PubMed         Abstract available

  13. LIU Z, Zhang J, Ding Q, Yang C, et al
    Real-time tracking of dual-labeled fluorescent SARS-CoV-2 reveals that the nucleocapsid mutations R203K/G204R accelerate viral uncoating.
    J Virol. 2026 Oct 6:e0108626. doi: 10.1128/jvi.01086.
    PubMed         Abstract available

  14. SILVA MARINHO PE, Ghimire D, Tsai Silva J, Devlin J, et al
    Subtype-specific differences in susceptibility to monoclonal antibodies and vaccines among contemporary RSV-A and RSV-B isolates.
    J Virol. 2026 Oct 5:e0122126. doi: 10.1128/jvi.01221.
    PubMed         Abstract available

  15. LI A, Si H, Wu K, Zhang Q, et al
    Natural variation in BtSARSr-CoV nsp12 harbors adaptive mutations that enhance viral replication and spillover risk in humans.
    J Virol. 2026 Oct 5:e0134326. doi: 10.1128/jvi.01343.
    PubMed         Abstract available


    J Virol Methods

  16. ZHAO M, Qiu P, Wang W, Li Y, et al
    A one-step multiplex real-time reverse transcription quantitative PCR assay for rapid and simultaneous detection of human parainfluenza virus, human metapneumovirus, and rhinovirus in patients with acute respiratory tract infection.
    J Virol Methods. 2026;348:115504.
    PubMed         Abstract available

  17. CAO D, Li J, Zu Y, Wang X, et al
    Development of a quantum dot-based immunochromatographic strip for the rapid detection of H9N2 subtype avian influenza virus.
    J Virol Methods. 2026;348:115503.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  18. WINN AK, Anglin O, Anderson EL, Prill MM, et al
    Respiratory Virus Activity - United States, July 2025-June 2026.
    MMWR Morb Mortal Wkly Rep. 2026;75:662-668.
    PubMed         Abstract available


    PLoS Comput Biol

  19. GOLDBERG EE, Kupperman MD, Ke R
    Estimating rates of SARS-CoV-2 lineage spread using graph spectra from genetic sequence data.
    PLoS Comput Biol. 2026;22:e1014920.
    PubMed         Abstract available


    PLoS One

  20. SANDES-FREITAS TV, Requiao-Moura L, Garcia VD, Manfro RC, et al
    Allograft function in kidney transplant recipients following COVID-19.
    PLoS One. 2026;21:e0356034.
    PubMed         Abstract available

  21. SATO S, Matsumoto M, Wakabayashi C, Oki I, et al
    Spatiotemporal analysis of COVID-19 in Japan: The twelve epidemic waves from 2020 to 2025.
    PLoS One. 2026;21:e0363045.
    PubMed         Abstract available

  22. MIGEON A, Laurent E, Chautard R, Desmars H, et al
    Bevacizumab and thrombosis risk in cancer patients with COVID-19: A national retrospective cohort study (TIC-TAC).
    PLoS One. 2026;21:e0362952.
    PubMed         Abstract available

  23. NIESSEN FA, Veldhuijzen IK, Boere TM, Hooiveld M, et al
    Developing a syndromic case definition for timely surveillance of severe acute respiratory infections (SARI) based on financial claim codes in the Netherlands.
    PLoS One. 2026;21:e0338157.
    PubMed         Abstract available

  24. THIT WM, Paek SC, Felix MS, Lamy FR, et al
    Misinformation-based preventive behaviors during the COVID-19 pandemic in Myanmar: A cross-sectional study.
    PLoS One. 2026;21:e0362976.
    PubMed         Abstract available

  25. CUGMAS M, Ferligoj A, Kogovsek T, Batagelj Z, et al
    Social support networks of older adults before, during and after the COVID-19 pandemic.
    PLoS One. 2026;21:e0363274.
    PubMed         Abstract available

  26. CHEN S, Cai M, Song Y, Xu Z, et al
    The global burden of Alzheimer's disease and related dementias: New public health intervention targets driven by the long-term impact of COVID-19 and sex and age differences.
    PLoS One. 2026;21:e0359947.
    PubMed         Abstract available

  27. ASAMNEW A, Shure W, Asres MS, Wondimeneh Y, et al
    Prevalence and associated factors of influenza A virus infection among patients with acute respiratory tract infections in Gondar City, Northwest Ethiopia.
    PLoS One. 2026;21:e0357953.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  28. RICHARDSON BD, Aiello AE, Hudgens MG
    Physical distancing to prevent influenza-like illness on a college campus: The eX-FLU trial.
    Proc Natl Acad Sci U S A. 2026;123:e2626810123.
    PubMed         Abstract available

  29. KIM D, Pasco R, Johnson KE, Fox SJ, et al
    Local influenza forecasts outperform state-level forecasts in the United States.
    Proc Natl Acad Sci U S A. 2026;123:e2616357123.
    PubMed         Abstract available


    Vaccine

  30. CAO Y, Kwan MYW, Murphy C, Chan ELY, et al
    Epidemiology of influenza C in Hong Kong inferred from pediatric hospitalization data.
    Vaccine. 2026;96:129278.
    PubMed         Abstract available


    Virology

  31. WU Y, Yu M, Feng L, Peng Q, et al
    Targeting TMPRSS2 protects against influenza-associated lung injury by suppressing PAR-2/MMP-9 axis.
    Virology. 2026;626:111142.
    PubMed         Abstract available


    Virus Res

  32. OUYANG F, Chen X, Wang M, Huang X, et al
    Serum untargeted metabolomics reveals infection-associated metabolic alterations in chikungunya, dengue, and influenza A virus infections.
    Virus Res. 2026 Nov 17:199832. doi: 10.1016/j.virusres.2026.199832.
    PubMed         Abstract available

  33. UEMURA K, Toba S, Kusakabe S, Sasaki M, et al
    In vivo antiviral efficacy and safety of 5-hydroxymethyltubercidin against DENV2 and SARS-CoV-2.
    Virus Res. 2026;373:199817.
    PubMed         Abstract available

Saturday, November 14, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Nov. 14 '26)

 


    Arch Virol

  1. ASHRAF MA, Yue L, Raza MA, Shen B, et al
    Isolation, identification and whole genome sequence analysis of influenza B virus from Shanghai during 2023-2024.
    Arch Virol. 2026;171:317.
    PubMed         Abstract available


    Drug Saf

  2. ROMANSON B, Moro PL, Strid P, Hause A, et al
    Safety Monitoring of COVID-19 Vaccines in the Vaccine Adverse Event Reporting System (VAERS): United States, August 22, 2024-July 4, 2025.
    Drug Saf. 2026;49:1639-1648.
    PubMed         Abstract available

  3. TREGUNNO C, Deraedt Q, Cuadripani S, Verheust C, et al
    AS01(E)-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine (Adjuvanted RSVPreF3): Review of the First 2 Years of Post-Marketing Safety Surveillance.
    Drug Saf. 2026;49:1579-1594.
    PubMed         Abstract available


    J Gen Virol

  4. NAIR PM, Zhang Y, Starkey MR, Jhong HT, et al
    Mitogen-activated protein kinase p38-dependent phosphorylation of tristetraprolin enhances inflammatory and impairs antiviral responses to influenza virus.
    J Gen Virol. 2026;107.
    PubMed         Abstract available

  5. SOULTSIOTI M, Barcena M, Giera M, Snijder EJ, et al
    Pharmacological inhibition of coronavirus replication via modulation of host lipid metabolism.
    J Gen Virol. 2026;107:002362.
    PubMed         Abstract available

  6. BLOUQUIT-LAYE S, Cosentino G, Sitterlin D, Rameix-Welti MA, et al
    A ciliated epithelial cell line as a model for respiratory syncytial virus research.
    J Gen Virol. 2026;107.
    PubMed         Abstract available


    N Engl J Med

  7. ZHANG Q, Fouchier RAM, Moncada-Velez M, Meijer A, et al
    Autoantibodies against Type I Interferons and Death from H7N7 Avian Influenza.
    N Engl J Med. 2026;395:1963-1965.
    PubMed        


    Pediatrics

  8. JARAMILLO-CEREZO A, Parra-Buitrago A, Ulloa-Gutierrez R, Gutierrez-Tobar IF, et al
    Beyond Croup: A Phenotype-Based Perspective on Parainfluenza Virus Types in Children.
    Pediatrics. 2026 Nov 13:e2026078012. doi: 10.1542/peds.2026-078012.
    PubMed         Abstract available


    PLoS Comput Biol

  9. BECKER F, Sherratt K, Bosse NI, Funk S, et al
    The influence of ensemble size and composition on the performance of combined real-time COVID-19 forecasts.
    PLoS Comput Biol. 2026;22:e1014908.
    PubMed         Abstract available


    PLoS Med

  10. TALL S, Turtinen M, Parviainen A, Pettersson J, et al
    Trends in the incidence of childhood type 1 diabetes after the COVID-19 lockdown in Finland: An observational study.
    PLoS Med. 2026;23:e1005288.
    PubMed         Abstract available


    PLoS One

  11. CARMICHAEL HL, Groat D, Dinglas VD, Bose S, et al
    Association of unmet discharge needs on readmission or mortality among acute respiratory failure survivors during the COVID-19 pandemic: The Addressing Post-Intensive Care Syndrome (APICS-COVID) multicenter prospective cohort study.
    PLoS One. 2026;21:e0361770.
    PubMed         Abstract available

  12. LANG Y, Griffiths A
    Validation of chemical inactivation methods for Select Agent compliance using HPAIV and low-pathogenicity influenza A virus in tissues and cultured cells.
    PLoS One. 2026;21:e0362117.
    PubMed         Abstract available

  13. VERCHER G, Pleydell DRJ, Awada L, Tizzani P, et al
    Factors influencing the timeliness of reporting highly pathogenic avian influenza outbreaks in Europe.
    PLoS One. 2026;21:e0360917.
    PubMed         Abstract available

  14. PHILLIPS R, Wood F, Torrens-Burton A, Glennan C, et al
    Evolving concerns: A longitudinal content analysis of free-text reports from the UK COVID-19 Public Experiences (COPE) study cohort.
    PLoS One. 2026;21:e0348308.
    PubMed         Abstract available

  15. CHIBA A, Haganuma K, Nakata T, Nguyen TL, et al
    COVID-19 risk perceptions after the end of the public health emergency.
    PLoS One. 2026;21:e0348400.
    PubMed         Abstract available

  16. GOLD S, Bell F, Sheard E, Ashoori A, et al
    Characterising the longer-term impacts of highly pathogenic avian influenza outbreaks prior to 2020 on wild bird populations.
    PLoS One. 2026;21:e0360235.
    PubMed         Abstract available

  17. DAY SE, Sorresso G, Fitzpatrick M, Konty K, et al
    Estimating diabetes prevalence among NYC youth: Evidence from the Automated Student Health Record.
    PLoS One. 2026;21:e0344345.
    PubMed         Abstract available

  18. BATTAGLIA S, Attanasio M, Arnone S, Geraci A, et al
    Prolonged length of stay in the Italian emergency departments: A competing risks frailty model.
    PLoS One. 2026;21:e0361888.
    PubMed         Abstract available

  19. HAILE TG, Asres N, Gebregziabher D, Fissahaye B, et al
    Intimate partner violence against women in Ethiopia: An umbrella review of systematic reviews and meta-analyses.
    PLoS One. 2026;21:e0362748.
    PubMed         Abstract available

  20. HO TL, Pham TT, Ko EJ
    Combined monophosphoryl lipid A and alpha-Galactosyl ceramide adjuvants enhance the systemic immune response to intranasal inactivated influenza vaccination in a murine homologous challenge model.
    PLoS One. 2026;21:e0362356.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  21. ANKERHOLD J, Kessler S, Petric PP, Jakob C, et al
    Rare recovery of reassortants between contemporary clade 2.3.4.4b H5N1 viruses and human influenza A viruses in vitro.
    Proc Natl Acad Sci U S A. 2026;123:e2631654123.
    PubMed         Abstract available

  22. SU S, Tang YS, Li Q, Cao L, et al
    Predicting key viral mutations from within-host deep sequencing data.
    Proc Natl Acad Sci U S A. 2026;123:e2536820123.
    PubMed         Abstract available


    Vaccine

  23. SUN JW, Dodge LE, Cai S, Zhou L, et al
    Monitoring of adverse events following 2024-2025 BNT162b2 KP.2 COVID-19 vaccination in the United States.
    Vaccine. 2026;95:129296.
    PubMed         Abstract available

  24. KOCHMANN J, Halwe NJ, Barut GT, Ebert N, et al
    Boosting hybrid immunity with intranasal live-attenuated or intramuscular mRNA vaccination prevents SARS-CoV-2 XBB.1.5 transmission.
    Vaccine. 2026;95:129298.
    PubMed         Abstract available

  25. BROSZ A, Oberije J, Versage E, Elfassy A, et al
    Immunogenicity and safety of two priming doses of an MF59-adjuvanted cell-based H5N8 influenza vaccine in healthy persons aged >/=18?years.
    Vaccine. 2026;96:129279.
    PubMed         Abstract available

  26. NEMOTO M, Kawanishi N, Mita H, Kambayashi Y, et al
    Discrepancy between cross-neutralizing reactivity and protection in horses suggests inactivated vaccine antisera underestimate cross-protection against equine influenza.
    Vaccine. 2026;96:129339.
    PubMed         Abstract available

Saturday, November 7, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Nov. 7 '26)

 


    Antiviral Res

  1. NAGAHAWATTA DP, Jeong SH, Liyanage NM, Jayawardena TU, et al
    Marine phlorotannins block SARS-CoV-2 entry via ACE2 and attenuate pulmonary inflammation in K18-hACE2 transgenic mice.
    Antiviral Res. 2026 Sep 15:106532. doi: 10.1016/j.antiviral.2026.106532.
    PubMed         Abstract available


    Arch Virol

  2. DANILENKO AV, Svyatchenko SV, Bragina MK, Goncharova NI, et al
    Characterization of influenza A(H3N2) viruses detected on a pig farm in Russia in 2017-2018.
    Arch Virol. 2026;171:314.
    PubMed         Abstract available


    BMC Pediatr

  3. ESTEVES L, Raymundo CE, de Andrade Medronho R
    Associated factors for COVID-19 mortality among children and adolescents in Rio de Janeiro state, 2020-2023.
    BMC Pediatr. 2026;26:1087.
    PubMed         Abstract available

  4. CHEN T, Guo X, Tang W, Liu F, et al
    Clinical characteristics and risk factors for poor prognosis of RSV lower respiratory tract infection: a two-center study.
    BMC Pediatr. 2026;26:1085.
    PubMed         Abstract available


    Epidemiol Infect

  5. LAU JY, Pan WC, Ji DD
    Transmission-route-specific trends in communicable diseases in Taiwan: an interrupted time-series analysis.
    Epidemiol Infect. 2026;154:e146.
    PubMed         Abstract available


    J Exp Med

  6. SUN R, Lin S, Simonelli L, Strunz B, et al
    Cellular origin and characterization of autoantibodies against type I IFNs in COVID-19 and APS-1.
    J Exp Med. 2026;223:e20260268.
    PubMed         Abstract available


    J Infect Dis

  7. MEEKER JR, Price AM, Martin E, Vaughn I, et al
    Influenza B Circulation and Vaccine Effectiveness Against Medically Attended Outpatient Influenza B Illness, United States, 2016-17 Through 2024-25.
    J Infect Dis. 2026 Oct 31:jiag538. doi: 10.1093.
    PubMed         Abstract available


    J Neurosurg Pediatr

  8. ROBERTS CR, Jin R, Parker M, Spader HS, et al
    A decade of change in pediatric intracranial abscess surgery: rising volumes and evolving care (2013-2023).
    J Neurosurg Pediatr. 2026;38:642-648.
    PubMed         Abstract available


    J Virol

  9. BIRD B, Thorn L, Aminisani N, Wood T, et al
    Incidence and risk factors of acute respiratory illness associated with influenza, COVID-19, and respiratory syncytial virus within a birth cohort study.
    J Virol. 2026 Nov 6:e0086326. doi: 10.1128/jvi.00863.
    PubMed         Abstract available


    Pediatrics


  10. Recommendations for COVID-19 Vaccines in Infants, Children, and Adolescents, 2026-2027: Policy Statement.
    Pediatrics. 2026 Sep 2. doi: 10.1542/peds.2026-079045.
    PubMed         Abstract available


  11. Recommendations for the Prevention of Respiratory Syncytial Virus Disease in Infants and Children: Technical Report.
    Pediatrics. 2026 Sep 2. doi: 10.1542/peds.2026-079049.
    PubMed         Abstract available


  12. Recommendations for COVID-19 Vaccines in Infants, Children, and Adolescents, 2026-2027: Technical Report.
    Pediatrics. 2026 Sep 2. doi: 10.1542/peds.2026-079046.
    PubMed         Abstract available


  13. Recommendations for the Prevention of RSV Disease in Infants and Children: Policy Statement.
    Pediatrics. 2026 Sep 2. doi: 10.1542/peds.2026-079047.
    PubMed         Abstract available

  14. ESTEBAN RIERA I, Perez-Caballero R, Natalini Martinez S, Gonzalez-Amores M, et al
    Immunogenicity and Safety of PHH-1V COVID-19 Vaccine as a Heterologous Booster in Adolescents.
    Pediatrics. 2026 Oct 23:e2026076225. doi: 10.1542/peds.2026-076225.
    PubMed         Abstract available

  15. HIGGINS DM, Gurfinkel D, Dorsey B, O'Leary ST, et al
    Frontline Staff Vaccine Communication During Pediatric Well-Child Encounters: A Mixed-Methods Study.
    Pediatrics. 2026 Oct 23:e2026077450. doi: 10.1542/peds.2026-077450.
    PubMed         Abstract available


    PLoS Comput Biol

  16. LEBATTEUX D, Corso F, Soudeyns H, Boucoiran I, et al
    KmerSignificance score: A discriminative and biologically informed framework for viral k-mer prioritization.
    PLoS Comput Biol. 2026;22:e1014332.
    PubMed         Abstract available


    PLoS Med

  17. BENJAMIN H, Barnsley G, Watson OJ, Jit M, et al
    Global return-on-investment of COVID-19 vaccines in the first year of the vaccination programme: A model-based economic evaluation.
    PLoS Med. 2026;23:e1004772.
    PubMed         Abstract available

  18. GAVISH N, Huppert A
    Transforming pandemic influenza antiviral stockpiling using a capacity-based approach: A modeling study.
    PLoS Med. 2026;23:e1004992.
    PubMed         Abstract available


    PLoS One

  19. WANG S, Xia Z, Shi B, Chen M, et al
    Weekly dynamics, subtype replacement and regional heterogeneity of influenza activity in China, 2024-2026: A national sentinel surveillance analysis.
    PLoS One. 2026;21:e0361588.
    PubMed         Abstract available

  20. ALKADI MM, Abuhelaiqa EA, Abdul Rahman RM, Mahgoub AB, et al
    Assessment of coronavirus disease 2019 mRNA vaccine response in kidney transplant recipients.
    PLoS One. 2026;21:e0359640.
    PubMed         Abstract available

  21. SVENSSON A, Sonnerfors P, Holmstrom L, Nygren-Bonnier M, et al
    Experiences of individually tailored physical exercise in COVID-19-induced postural orthostatic tachycardia syndrome: A qualitative content analysis.
    PLoS One. 2026;21:e0360748.
    PubMed         Abstract available

  22. ZHAO X, Deng L, Ford ND, Saydah S, et al
    Long COVID prevalence among U.S. adults: A state-level ecological analysis of associations with SARS-CoV-2 incidence, COVID-19 hospitalization rates, COVID-19 vaccine coverage, and multimorbidity.
    PLoS One. 2026;21:e0345433.
    PubMed         Abstract available

  23. CANIZALES GALAVIZ J, Khan A, Tourki B, Patarroyo-White S, et al
    eNAMPT is a plasma biomarker of COVID-19 severity and ARDS progression linked to increased immune effector cell expression.
    PLoS One. 2026;21:e0360244.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  24. SCHOWE AM, Ruks M, Disselkamp CKL, Kuznetsov DV, et al
    Epigenetic aging during the COVID-19 pandemic: A prospective longitudinal study with prepandemic baseline data in children, adolescents, and adults.
    Proc Natl Acad Sci U S A. 2026;123:e2604211123.
    PubMed         Abstract available

  25. CHARLESWORTH TES, Doyle MC, Banaji MR
    Patterns of implicit and explicit attitudes V: Increases in bias from 2021 to 2025.
    Proc Natl Acad Sci U S A. 2026;123:e2619420123.
    PubMed         Abstract available

  26. ZAPF AJ, Dewey G, Ognyanova K, Baum MA, et al
    Trust as a hidden driver of epidemic-relevant behavior: Institution- and behavior-specific associations across 20 national survey waves.
    Proc Natl Acad Sci U S A. 2026;123:e2622260123.
    PubMed         Abstract available


    Vaccine

  27. TRAN S, McClymont E, Blitz S, Barrett J, et al
    Erratum to "Self-reported reactogenicity after COVID-19 vaccination with and without influenza vaccine coadministration during pregnancy in Canada" [Vaccine 92 (2026) 129122].
    Vaccine. 2026 Oct 31:129306. doi: 10.1016/j.vaccine.2026.129306.
    PubMed        


    Virology

  28. DUDIN GA, Alkubaisi NA, Aziz IM, Ikram A, et al
    The role of cytokines as immunological biomarkers of disease severity during respiratory syncytial virus (RSV) infection in children.
    Virology. 2027;625:111102.
    PubMed         Abstract available

Saturday, October 31, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Oct. 31 '26)

 


    Arch Virol

  1. GUDYMO AS, Kolosova NP, Panova AS, Shadrinova KN, et al
    Contact transmission of fur seal-derived genotype A3 influenza A(H5N1) virus in ferrets.
    Arch Virol. 2026;171:313.
    PubMed         Abstract available


    Epidemiol Infect

  2. KONSTANTOPOULOU A, Velali K, Markopoulou P, Anastasiadou A, et al
    Impact of national RSV immunization programme on the epidemiology of bronchiolitis in Greece.
    Epidemiol Infect. 2026;154:e143.
    PubMed         Abstract available

  3. HAYES B, Lamielle G, Moon M, Padungtod P, et al
    Effectiveness of live-animal and environmental samples for detecting high pathogenicity avian influenza viruses in live-bird markets in Southeast Asia, 2015-2022.
    Epidemiol Infect. 2026 Oct 28:1-24. doi: 10.1017/S0950268826102246.
    PubMed        

  4. PLANCHAND S, Nivoix C, Fischer EAJ, Vergne T, et al
    Divide and reduce: systematic review and mathematical modelling of the impact of within-farm compartmentalisation on avian influenza transmission in poultry.
    Epidemiol Infect. 2026 Oct 27:1-30. doi: 10.1017/S0950268826102350.
    PubMed        

  5. SCOTT M, Browning L, Roberts T, De Boer J, et al
    An investigation into post-pandemic ethnic group and deprivation inequalities in influenza and COVID-19 hospitalizations.
    Epidemiol Infect. 2026;154:e139.
    PubMed         Abstract available


    J Clin Microbiol

  6. SHU B, Liddell J, Wong P, Duron ES, et al
    Update to the CDC influenza A(H3) subtyping assay for improved detection of influenza A(H3N2) viruses, including subclade K viruses.
    J Clin Microbiol. 2026 Oct 27:e0072726. doi: 10.1128/jcm.00727.
    PubMed         Abstract available


    J Immunol

  7. CHANG LA, Burgess E, Noureddine M, Wells AJ, et al
    Vaccine immunity can drive eosinophil recruitment in influenza breakthrough infection with mouse strain-specific outcomes.
    J Immunol. 2026;215:vkag279.
    PubMed         Abstract available


    J Virol

  8. FARRUKEE R, Xia Y, Morris R, Barnes JB, et al
    Bovine myxovirus resistance protein (Mx)1, but not Mx2, mediates antiviral activity against human and avian influenza A viruses, including H5N1 clade 2.3.4.4b.
    J Virol. 2026 Oct 28:e0137226. doi: 10.1128/jvi.01372.
    PubMed         Abstract available


    PLoS One

  9. ABDOLLAHI K, Rezaei Ghahroodi Z, Mansourian M
    Causal discovery and inference in COVID-19: A multiscale longitudinal analysis using mixtures of DAGs.
    PLoS One. 2026;21:e0355553.
    PubMed         Abstract available

  10. ZHANG L, Ton B, Mewton L, Schweizer S, et al
    Alcohol use and its associations with mental health across the first year of the COVID-19 pandemic.
    PLoS One. 2026;21:e0361854.
    PubMed         Abstract available

  11. TIAN Y, Richards DK, Cox MJ
    Temporal and seasonal trends in public interest in nonalcoholic beverages and lifestyles: A Google Trends analysis, 2004-2026.
    PLoS One. 2026;21:e0361032.
    PubMed         Abstract available

  12. BHUIYAN MRI, Sayem MA, Makhdum N
    Understanding the influencing factors of telemedicine service adoption in post-pandemic Bangladesh: An extended TAM and UTAUT2 model analysis.
    PLoS One. 2026;21:e0361691.
    PubMed         Abstract available

  13. STENGLER AL, Mattern E, Ronellenfitsch U, Steckelberg A, et al
    Experiences and challenges of healthcare professionals in oncological surgery during the COVID-19 pandemic: A qualitative study.
    PLoS One. 2026;21:e0361492.
    PubMed         Abstract available

  14. INUSAH AS, Xia H, Pasha A, Li Z, et al
    Longitudinal changes in BMI and obesity across COVID-19 pandemic periods among underrepresented populations: An analysis of the All of Us dataset.
    PLoS One. 2026;21:e0360745.
    PubMed         Abstract available

  15. HABIB MI, Sayeed MA, Islam M, Sarker MFR, et al
    Epidemiological characterization of avian influenza virus circulation in pigeons and quail across different production systems in Chattogram, Bangladesh.
    PLoS One. 2026;21:e0361561.
    PubMed         Abstract available

  16. MORITA T, Elsayed AMA, Hirakawa R, Lawal-Ayinde BM, et al
    Impact of low temperature on the efficacy of chlorous acid water and sodium hypochlorite solution for inactivating avian influenza virus on material surfaces.
    PLoS One. 2026;21:e0360392.
    PubMed         Abstract available

  17. GARCES-ARILLA S, Fidalgo C, Mendez-Lopez M, Hidalgo V, et al
    Health-related quality of life in women and men with long COVID.
    PLoS One. 2026;21:e0357749.
    PubMed         Abstract available

  18. SIMKHADA P, Lwin KS, Koirala B, Shrestha A, et al
    Barriers and facilitators of evidence-informed health policymaking in Nepal: A scoping review.
    PLoS One. 2026;21:e0358730.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  19. TURELLI P, Eray E, Raclot C, Trono D, et al
    Antigenic landscape of a highly mutated SARS-CoV-2 spike in ongoing viral evolution.
    Proc Natl Acad Sci U S A. 2026;123:e2608185123.
    PubMed         Abstract available

  20. NILFOROSHAN H, Reisler J, Jahanparast E, Moor M, et al
    Revised estimates of types and duration of long COVID symptoms based on claims records from 245 million US patients.
    Proc Natl Acad Sci U S A. 2026;123:e2604414123.
    PubMed         Abstract available


    Vaccine

  21. HUMBLE RM, Reifferscheid L, Gilbert NL, Dube E, et al
    Differences between Canadian parents' attitudes toward routine, influenza, and COVID-19 vaccines for their children, and changes in vaccine hesitancy since the pandemic: A national cross-sectional comparative study.
    Vaccine. 2026;96:129300.
    PubMed         Abstract available

  22. ZHANG J, Shen Y, Shi W, Ma J, et al
    End-of-season influenza vaccine effectiveness against a(H3N2) and B/Victoria in Beijing, China, 2025/26 season.
    Vaccine. 2026;96:129273.
    PubMed         Abstract available

  23. CHENG C, Chen X, Ge Y, Sung MH, et al
    Faster waning of immunity to influenza vaccine strains reintroduced into subsequent seasons: A human cohort study.
    Vaccine. 2026;95:129258.
    PubMed         Abstract available

  24. MISHIN VP, Patel MC, Gao R, Grant L, et al
    Hemagglutinin- and neuraminidase-targeting antibody responses after receipt of egg-based inactivated or recombinant influenza vaccines among adults aged 18-64?years.
    Vaccine. 2026;95:129281.
    PubMed         Abstract available

  25. CAI Z, Wang L, Ji S, Deng X, et al
    Quantifying the impact of pathogen interactions on vaccine effectiveness estimates in the test-negative design.
    Vaccine. 2026;94:129265.
    PubMed         Abstract available

  26. YAMAMOTO S, Matsuda K, Maeda K, Mizoue T, et al
    Protection of Omicron XBB.1.5 vaccine, previous infection, and their induced neutralizing antibodies against symptomatic SARS-CoV-2 infection during Omicron KP.3 wave.
    Vaccine. 2026;94:129242.
    PubMed         Abstract available

  27. MENEZES APO, Leite JLP, Pimenta FC, Larson S, et al
    Pneumococcal carriage and selected respiratory virus in children with clinical pneumonia in Salvador, Brazil during PCV10 era.
    Vaccine. 2026;94:129241.
    PubMed         Abstract available

  28. ISHII H, Miyauchi K, Harada S, Nakamura-Hoshi M, et al
    Intranasal immunization expressing S1 antigen can confer functionally sterile protection against an intranasal SARS-CoV-2 challenge in mice.
    Vaccine. 2026;94:129259.
    PubMed         Abstract available

  29. MAYR W, Knell AI, Boehm AK, Jager M, et al
    Longitudinal SARS-CoV-2 mRNA vaccine immunogenicity in inflammatory bowel disease in relation to anti-TNF therapy and age: a prospective cohort study.
    Vaccine. 2026;94:129224.
    PubMed         Abstract available

  30. MALIBWA D, Lees S, Ewing V, Deogratias D, et al
    Influence of COVID-19 and COVID-19 rumours on trust and uptake of single-dose male HPV vaccination in the Add-Vacc cluster-randomised trial, northwest Tanzania.
    Vaccine. 2026;94:129231.
    PubMed         Abstract available

  31. TOME J, Schwind JS, Richmond HL, Deloach B, et al
    Vaccine recipient and volunteer experiences from COVID-19 mass vaccine clinics at a university campus: drive-through and walk-through approaches.
    Vaccine. 2026;94:129229.
    PubMed         Abstract available

  32. PRASERT K, Nakphook S, Kittiwatanachod J, Ditsungneon D, et al
    Safety and immunogenicity of Thailand Government Pharmaceutical Organization (GPO) produced, COVID-19 vaccine, 10 mug HXP-GPOVac: A Phase III, double-blind, randomized trial in comparison with VAXZEVRIA.
    Vaccine. 2026;94:129230.
    PubMed         Abstract available


    Virology

  33. ARSANA A, Zhu W, Kang SM, Wang BZ, et al
    Towards influenza vaccine universality: Smart vaccine regimens and adjuvant-driven germinal center responses.
    Virology. 2026;625:111110.
    PubMed         Abstract available

  34. SEGALIN JT, Weiss M, de Almeida G, Lenhard BF, et al
    Genotypic and phenotypic characterization of the main endemic swine influenza A virus subtypes in Brazil.
    Virology. 2026;625:111099.
    PubMed         Abstract available

  35. ISAKOVA-SIVAK I, Matyushenko V, Rudenko L
    Influenza viruses as vaccine vectors: Historical background and future directions.
    Virology. 2026;625:111105.
    PubMed         Abstract available

Saturday, October 24, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Oct. 24 '26)

 


    BMC Pediatr

  1. PHUNG NTN, Tran TT, Van Nguyen N, Nguyen DH, et al
    Anticoagulation therapy in children with SARS-CoV-2 pneumonia: a retrospective observational study on dosage, efficacy, and safety.
    BMC Pediatr. 2026;26:1035.
    PubMed         Abstract available


    Epidemiol Infect

  2. OWUSU-BOAITEY N, Meyer MJ, Herrera-Esposito D, Bottcher L, et al
    Estimating COVID-19 cumulative incidence from seroprevalence surveys accounting for time-varying seroreversion: A fully Bayesian methodology.
    Epidemiol Infect. 2026;154:e137.
    PubMed         Abstract available


    J Infect

  3. PENG S, Deng Y, Liu J, Du X, et al
    From detection to prediction: Asymptomatic shedding-informed mass-balance modeling predicts travel-borne viral importation at airports.
    J Infect. 2026;93:106866.
    PubMed         Abstract available

  4. BERES SB, Pagnossin D, Olsen RJ, Long SW, et al
    Clinical and population genomic epidemiology of invasive group A streptococcus in Scotland, 2014-2024.
    J Infect. 2026 Sep 18:106860. doi: 10.1016/j.jinf.2026.106860.
    PubMed         Abstract available

  5. ORTEGA-FRANCISCO S, Prudente de Aquino MT, Chiuppesi F, Gutierrez-Franco MA Jr, et al
    Phase 2 evaluation of two GEO-CM04S1 dose levels shows comparable safety and broad immunogenicity.
    J Infect. 2026;93:106855.
    PubMed         Abstract available

  6. WALKER JL, Ribeiro S, Litt D, Patel T, et al
    Antenatal pertussis vaccine effectiveness in England remains high post COVID-19.
    J Infect. 2026;93:106836.
    PubMed         Abstract available


    J Virol

  7. MEINEKE R, Knittler M-C, Tagore R, Engling N, et al
    Respiratory syncytial virus-induced ADAM17 activity controls maintenance of epithelial barrier integrity and promotes syncytium formation.
    J Virol. 2026;100:e0115026.
    PubMed         Abstract available

  8. BUGA CC, Valerio M, Alenquer M, Pires de Miranda M, et al
    Insights into the mechanism of action of the bipartite fusion module of SARS-CoV-2 spike protein.
    J Virol. 2026 Sep 15:e0068826. doi: 10.1128/jvi.00688.
    PubMed         Abstract available

  9. RODRIGUEZ GALVAN J, de Vries M, Belblidia S, Fisher A, et al
    Airway protease availability governs a reversible shift between syncytial and cell-free spread.
    J Virol. 2026;100:e0072726.
    PubMed         Abstract available

  10. ALVARADO RE, Chen J, Lokugamage KG, Zhou Y, et al
    Antagonism of stress granules is key to SARS-CoV-2 infection and pathogenesis.
    J Virol. 2026 Sep 8:e0099226. doi: 10.1128/jvi.00992.
    PubMed         Abstract available


    PLoS One

  11. FOOX Y, Yamin D, Chalutz-BenGal H, Ben-Gal I, et al
    Applying normalized p-control charts for early detection of local COVID-19 outbreaks.
    PLoS One. 2026;21:e0357183.
    PubMed         Abstract available

  12. SONG A, Zuvia C, Talbot P
    Susceptibility of human neural stem cells to SARS-CoV-2: Entry mechanisms and glycocalyx influence.
    PLoS One. 2026;21:e0360734.
    PubMed         Abstract available

  13. THOMAS C, Ashton RE, Pretorius E, Owen R, et al
    Blood biomarkers of long COVID: A cross-sectional evaluation of key cytokines and the coordination of inflammation.
    PLoS One. 2026;21:e0360525.
    PubMed         Abstract available

  14. REDMAN WT, Mullany LC
    Data-driven forecasting of Flu, RSV, and COVID-19 related outcomes in the United States and Canada via Hankel dynamic mode decomposition.
    PLoS One. 2026;21:e0360068.
    PubMed         Abstract available

  15. MAHMOOD B, Hu J, Tang TS, Adu P, et al
    Impact of the COVID-19 pandemic and control measures on type 2 diabetes care among South Asians: the perspective of healthcare providers in British Columbia, Canada.
    PLoS One. 2026;21:e0359295.
    PubMed         Abstract available

  16. JUHASZ L, Garba NA, Moise IK, Bhoite PB, et al
    The detection paradox: How COVID-19 surveillance patterns shifted from lower-income to more affluent neighborhoods in Miami-Dade County.
    PLoS One. 2026;21:e0361211.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  17. HVID U, Nielsen BF, Sneppen K
    Bridging spatial scales in respiratory viral infection.
    Proc Natl Acad Sci U S A. 2026;123:e2614436123.
    PubMed         Abstract available


    Vaccine

  18. KROKHIN A, Romanova J, Grillari R, Hackl M, et al
    AEX-1: A Vero cell variant with enhanced permissiveness for influenza virus replication.
    Vaccine. 2026;94:129237.
    PubMed         Abstract available

  19. XU S, Sy LS, Hong V, Farrington P, et al
    Ischemic stroke after bivalent mRNA COVID-19 vaccination and influenza vaccination during the 2022-2023 season: a multi-site self-controlled case series study.
    Vaccine. 2026;95:129263.
    PubMed         Abstract available


    Virology

  20. RZYMSKI P, Malecka I, Szczepanska B, Wasielewska Z, et al
    RSV, influenza, and COVID-19 in hospitalized children: A comparative analysis of the 2025/2026 epidemic season in Poland.
    Virology. 2026;625:111104.
    PubMed         Abstract available

Saturday, October 17, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Oct. 17 '26)

 


    Epidemiol Infect

  1. ONTAS E
    Establishing influenza epidemic thresholds and intensity levels in Turkiye using the moving epidemic method and assessing concordance with WHO transmission zones: A sentinel surveillance analysis of ten seasons, 2013-2025.
    Epidemiol Infect. 2026;154:e129.
    PubMed         Abstract available

  2. KUMBAROFF Z, Harvey EP, Whitehead J, O'Neale DRJ, et al
    Ethnic inequities in mathematical models for respiratory infectious disease: A systematic review.
    Epidemiol Infect. 2026;154:e130.
    PubMed         Abstract available

  3. HAUSER-VAN WESTRHENEN ESEM, De Hoog MLA, Winkel AMAM, Junquera Guinovart L, et al
    Viral interference with SARS-CoV-2 during the COVID-19 pandemic: An individual participant data meta-analysis.
    Epidemiol Infect. 2026;154:e128.
    PubMed         Abstract available

  4. TRIGO F, Guillen JM, Hernandez-Barrera V, Gil R, et al
    Burden of RSV hospital disease and its comorbidities in adults in Spain (2016-2023).
    Epidemiol Infect. 2026;154:e127.
    PubMed         Abstract available

  5. PILAPIL JD, Mata MA, Del Rosario R, Pasciolco MJ, et al
    Genomic surveillance of COVID-19 in Hong Kong (2020-2023): Analysing SARS-CoV-2 variants, mutations, and their impact on viral entry.
    Epidemiol Infect. 2026;154:e124.
    PubMed         Abstract available

  6. SPRONK M, Boyd A, Campman SL, Jongen V, et al
    Presence of post-COVID-19 condition in six ethnic groups in Amsterdam, the Netherlands: a retrospectively reconstructed time interval approach.
    Epidemiol Infect. 2026;154:e121.
    PubMed         Abstract available


    J Clin Microbiol

  7. HEIMSCH KC, Stanoeva KR, Visser I, Rahou Y, et al
    SARS-CoV-2 and RSV external quality assessment on molecular detection and variant typing in European expert laboratories in 2025.
    J Clin Microbiol. 2026;64:e0025826.
    PubMed         Abstract available

  8. SMITH K, Martinez J, Yu H, Harrison J, et al
    Development and evaluation of an ARTIC-based amplicon sequencing assay for whole-genome characterization of respiratory syncytial virus.
    J Clin Microbiol. 2026;64:e0046826.
    PubMed         Abstract available


    J Immunol

  9. KOUTSAKOS M, Crawford JC, Grzelak L, Rizzetto S, et al
    TCRalphabeta repertoire plasticity defines universal CD8+ T cell responses directed at influenza-specific HLA-A*02:01-PB1413-421 epitope.
    J Immunol. 2026;215:vkag270.
    PubMed         Abstract available


    J Infect Dis

  10. BAI X, Chen S, Yin S, Zhao Q, et al
    Characterization of Mucosal BPI fold-containing family A member 1-High-Expressing Neutrophils and their Immune Defense roles in Severe Acute Respiratory Syndrome Coronavirus 2 Breakthrough Infection via single-cell RNA sequencing.
    J Infect Dis. 2026;234:583-593.
    PubMed         Abstract available

  11. NARAYAN K, Tosh K, Holmes A, Hu L, et al
    Serum Virus-Neutralizing Antibody Titers in Clinical Trial Participants With and Without Immunocompromise Receiving Pemivibart, a Long-Acting Monoclonal Antibody for COVID-19.
    J Infect Dis. 2026;234:e859-e868.
    PubMed         Abstract available

  12. AVADHANULA V, Bournat J, Ferlic-Stark LL, Bond NL, et al
    Impact of Low Community Circulation of Respiratory Syncytial Virus (RSV) on Immunity Debt Against RSV in Adults During the Coronavirus Disease 2019 Pandemic.
    J Infect Dis. 2026;234:564-572.
    PubMed         Abstract available

  13. SUTCLIFFE CG, Sergent VM, Yazzie D, Brasinikas G, et al
    Post-COVID Rebound in Invasive Pneumococcal Disease Driven by Resurgence of Serotype 4 Among American Indian Individuals in the Southwest United States.
    J Infect Dis. 2026;234:e908-e921.
    PubMed         Abstract available

  14. MOORE HC, Foo D, Giannini F, Minney-Smith C, et al
    What is the Optimal RSV Immunization Strategy for Infants Born in the RSV Off-season?
    J Infect Dis. 2026;234:e823-e828.
    PubMed         Abstract available

  15. EPSI NJ, Richard SA, Morris MJ, Lindholm DA, et al
    Is Cellular Senescence a Biological Feature of Long COVID? A Transcriptomic Analysis Across Comparative Postacute Sequelae Phenotypes.
    J Infect Dis. 2026;234:e869-e880.
    PubMed         Abstract available

  16. PEREZ-GARCIA C, Llorente J, Aguirre Alastuey ME, Llamosi M, et al
    Lineage Dynamics and Risk Factors Underlying Serotype 4 Invasive Pneumococcal Disease in Spain.
    J Infect Dis. 2026;234:e922-e934.
    PubMed         Abstract available

  17. WAN T, Lautenbach E, Mannathoko N, Mosepele M, et al
    Diverse genetic lineages spreading across healthcare and community boundaries underlie extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) colonization burden in Botswana.
    J Infect Dis. 2026 Jul 7:jiag342. doi: 10.1093.
    PubMed         Abstract available

  18. LEIS AM, Han JH, Hough CL
    Beyond the Acute Illness: Three Myths About Viral Respiratory Infection.
    J Infect Dis. 2026;234:513-515.
    PubMed         Abstract available


    J Virol

  19. WILLIAMS SL, Gygli SM, Bjorgen JC, Fan H, et al
    Avian influenza A virus polymerase gene leads to temperature-resistant genome replication.
    J Virol. 2026 Oct 13:e0097826. doi: 10.1128/jvi.00978.
    PubMed         Abstract available


    PLoS Biol

  20. NIU C, Huang X, Yan Q, Liu B, et al
    R1-32-like public antibodies acquire tolerance to SARS-CoV-2 antigenic drift through somatic hypermutation.
    PLoS Biol. 2026;24:e3003996.
    PubMed         Abstract available


    PLoS One

  21. BHUKHAI K, Tanhuad N, Srimorkun P, Manopwisedjaroen S, et al
    Omicron SARS-CoV-2 shows NRP1-linked susceptibility in adipose-derived MSCs and alters primitive cord blood CD34(+) HSPCs.
    PLoS One. 2026;21:e0360439.
    PubMed         Abstract available

  22. SADIQ M, Wasim B, Khatoon A, Kumar A, et al
    Whole-exome sequencing identifies a missense variant in the cytoskeletal gene SVIL implicating actin remodeling in COVID-19 severity in a Pakistani cohort.
    PLoS One. 2026;21:e0360429.
    PubMed         Abstract available

  23. REZENDE LMT, Silva KVC, Cuadro A, Signes VM, et al
    Consequences of COVID-19 infection on educators' executive functions: A systematic review and meta-analysis protocol.
    PLoS One. 2026;21:e0350156.
    PubMed         Abstract available

  24. LI X, Ding J, Zhang Y, Hu T, et al
    Measuring destination image dissonance: A compositional data analysis of cross-media representations in Sanya's Tourism.
    PLoS One. 2026;21:e0360383.
    PubMed         Abstract available

  25. YANG Y, Juntila-Raymond C, Callear A, Smith M, et al
    Evaluation of pre-Omicron population immunity for SARS-CoV-2 in the Household Influenza Vaccine Evaluation (HIVE) cohort.
    PLoS One. 2026;21:e0360506.
    PubMed         Abstract available

  26. VERFAILLIE SCJ, Verveen A, Visser D, Nieuwkerk P, et al
    Post-acute sequelae of COVID-19 (PASC) are associated with distinct clinical phenotypes two years after SARS-CoV-2 infection: A data-driven approach.
    PLoS One. 2026;21:e0359844.
    PubMed         Abstract available

  27. NGAMALEU MR, Tene H, Djounda R, Minomo R, et al
    Early inflammation-driven damage and delayed viral clearance are associated with prolonged biliary perturbation in a Cameroonian cohort of COVID-19 patients.
    PLoS One. 2026;21:e0357503.
    PubMed         Abstract available

  28. JUNG H, Jung M
    A retrospective epidemiological study of screening-derived solid cancer incidence proxy rates in South Korea before and after COVID-19 using Korean National Health Insurance Service data.
    PLoS One. 2026;21:e0360040.
    PubMed         Abstract available


    Vaccine

  29. BOER M, Klugkist I, Kroese F
    Educational background and vaccination beliefs in the Netherlands: A Bayesian Evidence Synthesis from four studies.
    Vaccine. 2026;93:129132.
    PubMed         Abstract available

  30. SAIKI S, Kuroiwa M, Hashimoto K, Nakajima-Yoshida H, et al
    LP.8.1-directed recombinant protein COVID-19 vaccine S-268025, formulated with squalene-based adjuvant A-910823, elicits robust immunogenicity and neutralizing breadth in mice.
    Vaccine. 2026;93:129177.
    PubMed         Abstract available

  31. BAZARJAV P, Erdene-Ochir T, Sandagdorj A, Enkhtuvshin A, et al
    One-year antibody kinetics and effectiveness of a BNT162b2 booster after four primary COVID-19 vaccination regimens in Mongolia.
    Vaccine. 2026;93:129179.
    PubMed         Abstract available

  32. GOULD S, Rohde CM, Destexhe E, Tiesjema B, et al
    Summary of 2025 Society of Toxicology Workshop "Vaccine Toxicology in the Post-COVID Era".
    Vaccine. 2026;93:129180.
    PubMed         Abstract available

  33. BRADY C, Govender M, Mellors J, Tipton T, et al
    Spike antibody Fc is associated with protection from SARS-CoV-2 challenge in macaques.
    Vaccine. 2026;93:129192.
    PubMed         Abstract available

  34. SHICHINOHE S, Li Q, Tanaka H, Anindita J, et al
    Cross-clade protection against human H5N1 isolates by a clade 2.3.4.4b HA mRNA vaccine in mice.
    Vaccine. 2026;93:129215.
    PubMed         Abstract available

  35. BEOGO I, Xu Y, Kibret TC, Muray M, et al
    Perception of COVID-19 vaccine effectiveness perception in older racialized communities: role of major racial discrimination and health literacy.
    Vaccine. 2026;93:129214.
    PubMed         Abstract available

  36. BEOGO I, Kibret TC, Zhang Q, Muray M, et al
    Ethnic disparities in COVID-19 vaccine uptake among among 55+ year-old Canadians: Exploring the role of racial discrimination, chronic disease comorbidities, and conspiracy beliefs.
    Vaccine. 2026;93:129213.
    PubMed         Abstract available

  37. KOPP L, Hofner B, Mentzer D
    Mobile-app-based cohort event monitoring study (CEM) of COVID-19 vaccines.
    Vaccine. 2026;93:129219.
    PubMed         Abstract available

  38. MARQUES DFP, Howard J, Alvarez ML, Machado A, et al
    Comparing two case definitions for including severe acute respiratory infection patients in influenza and COVID-19 vaccine effectiveness studies among older adults using the test-negative design: VEBIS hospital network, seven European countries, 2023/
    Vaccine. 2026;94:129234.
    PubMed         Abstract available

The #Risk of an #H5N1 #Influenza #Pandemic

 


Abstract

The last 110 years have seen four influenza A pandemics, where viruses have emerged from mammals or birds with the ability to transmit and cause disease in human populations. Since 2021, a high-pathogenicity strain of avian influenza, H5N1, has caused a panzootic (pandemic of animals), with global spread in wild birds, resulting in frequent spillovers into farmed poultry and into mammals, including mammal species not previously known to be affected by influenza A. This has created increased opportunity for reassortment, mutation, human infection, and potential adaptation to transmit. The risk to humans and the impact are difficult to quantify but of mounting concern to public health bodies. Here, we examine the risk of an H5N1 pandemic emerging and spreading in humans and the potential impact of an H5N1 pandemic.

Source: 


Link: https://doi.org/10.1146/annurev-med-042525-092552

____

Saturday, October 10, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Oct. 10 '26)

 


    Antimicrob Agents Chemother

  1. LIU S, Qiu X, Guo S, Wang L, et al
    Mechanistic blockade of RSV infection by a pre-F targeting single-domain antibody-Fc fusion protein.
    Antimicrob Agents Chemother. 2026;70:e0054126.
    PubMed         Abstract available


    BMC Pediatr

  2. APPEL S, Coughtrey AE, Kyrdalen A, Takeda A, et al
    Understanding heterogeneity in paediatric long COVID research: an overview of reviews and recommendations for future pandemics.
    BMC Pediatr. 2026;26:937.
    PubMed         Abstract available


    J Immunol

  3. SEGARD A, Goguet E, Haines-Hull H, Williamson KC, et al
    Effects of natural killer cell depletion on innate and adaptive immune responses to COVID mRNA vaccination.
    J Immunol. 2026;215:vkag266.
    PubMed         Abstract available


    J Infect Dis


  4. Correction to: Introduction and Update: Advances in Influenza Therapeutics.
    J Infect Dis. 2026 Oct 8:jiag499. doi: 10.1093.
    PubMed        


    J Virol

  5. CIACCI ZANELLA G, Vincent ML, Flores L, Aljets EK, et al
    A multivalent mRNA-lipid nanoparticle vaccine containing eight hemagglutinin antigens elicited broad neutralizing antibody responses and protected against influenza A virus challenge in swine.
    J Virol. 2026 Oct 9:e0084826. doi: 10.1128/jvi.00848.
    PubMed         Abstract available

  6. SOUZA CK, Santos JJS, Boggiatto P, Sterle H, et al
    H5 influenza virus mRNA-lipid nanoparticle (LNP) vaccination elicits adaptive immune responses in Holstein calves.
    J Virol. 2026 Oct 8:e0128926. doi: 10.1128/jvi.01289.
    PubMed         Abstract available

  7. DEL ROSARIO JMM, van Diemen PM, Frost SDW, Vishwanath S, et al
    A digitally immune-optimized influenza vaccine broadly neutralizes swine and human H1N1 influenza viruses and protects from heterologous challenge.
    J Virol. 2026 Oct 6:e0107326. doi: 10.1128/jvi.01073.
    PubMed         Abstract available

  8. NOORUZZAMAN M, Buchholz DW, Rani R, de Oliveira PSB, et al
    Infection and transmission dynamics of bovine and human influenza A H5N1 viruses in mouse and hamster models.
    J Virol. 2026 Oct 6:e0104426. doi: 10.1128/jvi.01044.
    PubMed         Abstract available


    PLoS One

  9. ZAIR X, Wilm A, Benton MC, Tham CY, et al
    Sub-consensus haploid variant calling in long-read sequencing technology.
    PLoS One. 2026;21:e0356259.
    PubMed         Abstract available

  10. RAMIREZ-SOTO MC, Arroyo-Hernandez H, Machuca JVB, Stalder DH, et al
    Pneumonia incidence, hospitalizations and mortality before and during the COVID-19 pandemic in Peru: An observational study.
    PLoS One. 2026;21:e0351171.
    PubMed         Abstract available

  11. YEO D, Woo S, Kim J, Kim K, et al
    Exposure to residential greenness and subsequent risk of common mental disorders among individuals with COVID-19 in South Korea: A nationwide cohort study.
    PLoS One. 2026;21:e0359016.
    PubMed         Abstract available

  12. ANGRISANI M, Atella V, Bruine de Bruin W, Kopinska J, et al
    How personality traits shape susceptibility to mental distress in times of crisis: Evidence from the COVID-19 pandemic.
    PLoS One. 2026;21:e0358371.
    PubMed         Abstract available

  13. PENG Q, Wu M, Feng Q
    Service-oriented reallocation and value-added intensity in China's sport industry, 2018-2024: A longitudinal accounting analysis.
    PLoS One. 2026;21:e0354049.
    PubMed         Abstract available

  14. POQUET D, Le Gal C, Hincker P, Beghin L, et al
    Reach and engagement in the ECAIL trial targeting socially disadvantaged families across the COVID-19 pandemic and cost-of-living crisis: A mixed-methods implementation study.
    PLoS One. 2026;21:e0350372.
    PubMed         Abstract available

  15. KANMA-OKAFOR OJ, Ravi P, Ngaybe MGB, Yusoof K, et al
    Enrollment in participatory surveillance programs and influenza vaccination uptake: A systematic review protocol.
    PLoS One. 2026;21:e0358599.
    PubMed         Abstract available

  16. MYAT KYAW HM, Li Y, Chan DKC, Capio CM, et al
    COVID-19 infection and Hong Kong elementary children's Chinese and English reading proficiencies: Parent-reported proficiency versus performance-based reading tests.
    PLoS One. 2026;21:e0359793.
    PubMed         Abstract available

  17. GUMMER T, Lu KH, von Glasenapp K
    Assessing the FAIRness of survey data collected during the COVID-19 pandemic in Germany.
    PLoS One. 2026;21:e0358755.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  18. ALSTON H, Mora T, Walczak AM
    Neutralization titers reveal the structure of polyclonal antibody responses.
    Proc Natl Acad Sci U S A. 2026;123:e2612096123.
    PubMed         Abstract available


    Vaccine

  19. JEONG O, Kim PK, Oh H, Lee K, et al
    Sequence-Aware Antigenic Alignment and SRID Potency Interpretation in Influenza Vaccines.
    Vaccine. 2026;93:129191.
    PubMed         Abstract available

My New Space

Most Popular Posts